The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
Abstract
RATIONALE: Accurate prediction of mortality helps select patients for interventions aimed at improving outcome. OBJECTIVES: Because chronic obstructive pulmonary disease is characterized by low-grade systemic inflammation, we hypothesized that addition of inflammatory biomarkers to established predictive factors will improve accuracy. METHODS: A total of 1,843 patients enrolled in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study were followed for 3 years. Kaplan-Meier curves, log-rank analysis, and Cox proportional hazards analyses determined the predictive value for mortality of clinical variables, while C statistics assessed the added discriminative power offered by addition of biomarkers. MEASUREMENTS AND MAIN RESULTS: At recruitment we measured anthropometrics, spirometry, 6-minute walk distance, dyspnea, BODE index, history of hospitalization, comorbidities, and computed tomography scan emphysema. White blood cell and neutrophil counts, serum or plasma levels of fibrinogen, chemokine ligand 18, surfactant protein D, C-reactive protein, Clara cell secretory protein-16, IL-6 and -8, and tumor necrosis factor-α were determined at recruitment and subsequent visits. A total of 168 of the 1,843 patients (9.1%) died. Nonsurvivors were older and had more severe airflow limitation, increased dyspnea, higher BODE score, more emphysema, and higher rates of comorbidities and history of hospitalizations. The best predictive model for mortality using clinical variables included age, BODE, and hospitalization history (C statistic of 0.686; P < 0.001). One single biomarker (IL-6) significantly improved the C statistic to 0.708, but this was further improved to 0.726 (P = 0.003) by the addition of all biomarkers. CONCLUSIONS: The addition of a panel of selected biomarkers improves the ability of established clinical variables to predict mortality in chronic obstructive pulmonary disease. Clinical trial registered with www.clinicaltrials.gov (NCT00292552).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citationCelli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 2×
“The BODE index was calculated as previously reported (8).”
BackgroundMethodSelf-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationRabe, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · Cited by 2,567
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,079
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Self-citationPencina, M. J., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,444
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157 · cited 1×
“All methods have been described in the baseline and protocol (20, 21) ECLIPSE manuscripts.”
MethodSelf-citationDyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in Patients With COPD
Nishimura, K., Izumi, T., Tsukino, M., & Oga, T. (2002) · Chest · doi:10.1378/chest.121.5.1434 · Cited by 996
Changes in Forced Expiratory Volume in 1 Second over Time in COPD
Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105482 · Cited by 963
Self-citationUse of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Prognosis in Chronic Obstructive Pulmonary Disease 1– 3
Anthonisen, N. R., Wright, E. C., Hodgkin, J. E., & IPPB Trial Group (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.133.1.14 · Cited by 777
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Vestbo, J., Anderson, W., Coxson, H. O., Crim, C., Dawber, F., Edwards, L., Hagan, G., Knobil, K., Lomas, D. A., MacNee, W., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00111707 · Cited by 759
Self-citationBody composition and mortality in chronic obstructive pulmonary disease
Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.53 · Cited by 658
Self-citationOga, T., Nishimura, K., Tsukino, M., Sato, S., & Hajiro, T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-583oc · Cited by 594
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 543
Self-citationPuhan, M. A., Garcia-Aymerich, J., Frey, M., ter Riet, G., Antó, J. M., Agustí, A. G., Gómez, F. P., Rodríguez-Roisín, R., Moons, K. G., Kessels, A. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61301-5 · Cited by 521
Self-citationRaised CRP levels mark metabolic and functional impairment in advanced COPD
Broekhuizen, R. (2005) · Thorax · doi:10.1136/thx.2005.041996 · Cited by 439
C-reactive protein in patients with COPD, control smokers and non-smokers
Pinto-Plata, V. M. (2005) · Thorax · doi:10.1136/thx.2005.042200 · Cited by 435
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Man, S. F. P. (2006) · Thorax · doi:10.1136/thx.2006.059808 · Cited by 397
A time‐dependent discrimination index for survival data
Antolini, L., Boracchi, P., & Biganzoli, E. (2005) · Statistics in Medicine · doi:10.1002/sim.2427 · Cited by 339
Coming together: the ATS/ERS consensus on clinical pulmonary function testing
Brusasco, V., Crapo, R., & Viegi, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034205 · Cited by 313
References values for forced spirometry. Group of the European Community Respiratory Health Survey
Roca, J., Burgos, F., Sunyer, J., Saez, M., Chinn, S., Anto, J., Rodriguez-Roisin, R., Quanjer, P., Nowak, D., & Burney, P. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11061354 · Cited by 291
Jones, R. C., Donaldson, G. C., Chavannes, N. H., Kida, K., Dickson-Spillmann, M., Harding, S., Wedzicha, J. A., Price, D., & Hyland, M. E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0271oc · Cited by 262
Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD
Lomas, D. A., Silverman, E. K., Edwards, L. D., Locantore, N. W., Miller, B. E., Horstman, D. H., & Tal-Singer, R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00156508 · Cited by 235
Self-citationEvaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort
Lomas, D. A., Silverman, E. K., Edwards, L. D., Miller, B. E., Coxson, H. O., Tal-Singer, R., & on behalf of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators (2008) · Thorax · doi:10.1136/thx.2008.102574 · Cited by 213
Self-citationProfiling serum biomarkers in patients with COPD: associations with clinical parameters
Pinto-Plata, V., Toso, J., Lee, K., Park, D., Bilello, J., Mullerova, H., De Souza, M. M., Vessey, R., & Celli, B. (2007) · Thorax · doi:10.1136/thx.2006.064428 · Cited by 205
Self-citationValidation and comparison of reference equations for the 6-min walk distance test
Cote, C. G., Casanova, C., Marín, J. M., Lopez, M. V., Pinto-Plata, V., de Oca, M. M., Dordelly, L. J., Nekach, H., & Celli, B. R. (2008) · European Respiratory Journal · doi:10.1183/09031936.00104507 · Cited by 204
Self-citationC-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD
de Torres, J. P., Pinto-Plata, V., Casanova, C., Mullerova, H., Córdoba-Lanús, E., de Fuentes, M. M., Aguirre-Jaime, A., & Celli, B. R. (2008) · Chest · doi:10.1378/chest.07-2433 · Cited by 169
Self-citationCalfee, C. S., Ware, L. B., Glidden, D. V., Eisner, M. D., Parsons, P. E., Thompson, B., & Matthay, M. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318207ec3c · Cited by 122
Emerging Pharmacotherapies for COPD
Barnes, P. J. (2008) · CHEST Journal · doi:10.1378/chest.08-1385 · Cited by 117
Serum PARC/CCL-18 Concentrations and Health Outcomes in Chronic Obstructive Pulmonary Disease
Sin, D. D., Miller, B. E., Duvoix, A., Man, S. F. P., Zhang, X., Silverman, E. K., Connett, J. E., Anthonisen, N. A., Wise, R. A., Tashkin, D. P., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1220oc · Cited by 115
Self-citationCirculating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Man, S. F. P., Xing, L., Connett, J. E., Anthonisen, N. R., Wise, R. A., Tashkin, D. P., Zhang, X., Vessey, R., Walker, T., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00153207 · Cited by 61
Self-citationPredictors of Mortality in Elderly Subjects with Obstructive Airway Disease: The PILE Score
Mehrotra, N., Freire, A. X., Bauer, D. C., Harris, T. B., Newman, A. B., Kritchevsky, S. B., & Meibohm, B. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.11.005 · Cited by 43
Cited by
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
Rincon, M., & Irvin, C. G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4874 · Cited by 621
Mindfulness meditation and the immune system: a systematic review of randomized controlled trials
Black, D. S., & Slavich, G. M. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12998 · Cited by 599
A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors
Kaur, S., Bansal, Y., Kumar, R., & Bansal, G. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115327 · Cited by 449
A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
Weiss, D. J., Casaburi, R., Flannery, R., LeRoux-Williams, M., & Tashkin, D. P. (2013) · Chest · doi:10.1378/chest.12-2094 · Cited by 423
Metadata
- Authors
- Celli, B. R., Locantore, N., Yates, J., Tal-Singer, R., Miller, B. E., Bakke, P., Calverley, P., Coxson, H., Crim, C., Edwards, L. D., Lomas, D. A., Duvoix, A., MacNee, W., Rennard, S., Silverman, E., Vestbo, J., Wouters, E., Agustí, A., & for the ECLIPSE Investigators
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-15
- Volume
- 185
- Issue
- 10
- Pages
- 1065-1072
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2154204110
- Cited by
- 432
- References
- 36
- FWCI
- 36.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.